找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Bone Drugs in Pediatrics; Efficacy and Challen Gordon L. Klein Book 2014 Springer Science+Business Media New York 2014 Anti-resorptive.Bisp

[復(fù)制鏈接]
查看: 28120|回復(fù): 45
樓主
發(fā)表于 2025-3-21 16:26:24 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱(chēng)Bone Drugs in Pediatrics
期刊簡(jiǎn)稱(chēng)Efficacy and Challen
影響因子2023Gordon L. Klein
視頻videohttp://file.papertrans.cn/190/189665/189665.mp4
發(fā)行地址Presents evidence for the use of certain drugs in the treatment and prevention of bone loss in children.Balances the pros and cons of utilizing these drugs in the pediatric population.Highlights the p
圖書(shū)封面Titlebook: Bone Drugs in Pediatrics; Efficacy and Challen Gordon L. Klein Book 2014 Springer Science+Business Media New York 2014 Anti-resorptive.Bisp
影響因子.Bone Drugs in Pediatrics. brings together in one place the evidence for the use of certain drugs in the treatment and prevention of bone loss in children, as well as the reservations still present in the pediatric community regarding their use. Beginning with a discussion of developmental pharmacokinetics and drug development for pediatric diseases where bone loss occurs, such as osteogenesis imperfecta, the physiology of pediatric bone and how best to monitor the safety and efficacy of these drugs is presented. The pros and cons of utilizing the drugs themselves – such as bisphosphonates, antiresorptives and anabolic agents – within the pediatric population are carefully considered, with an eye toward safe and effective integration. The potential use of drugs in future treatment is also highlighted. On the whole, .Bone Drugs in Pediatrics .is a cogent presentation of the ongoing debate surrounding the potential for pharmacological interventions in pediatric bone loss.
Pindex Book 2014
The information of publication is updating

書(shū)目名稱(chēng)Bone Drugs in Pediatrics影響因子(影響力)




書(shū)目名稱(chēng)Bone Drugs in Pediatrics影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Bone Drugs in Pediatrics網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Bone Drugs in Pediatrics網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Bone Drugs in Pediatrics被引頻次




書(shū)目名稱(chēng)Bone Drugs in Pediatrics被引頻次學(xué)科排名




書(shū)目名稱(chēng)Bone Drugs in Pediatrics年度引用




書(shū)目名稱(chēng)Bone Drugs in Pediatrics年度引用學(xué)科排名




書(shū)目名稱(chēng)Bone Drugs in Pediatrics讀者反饋




書(shū)目名稱(chēng)Bone Drugs in Pediatrics讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:54:45 | 只看該作者
Drug Development for Pediatric Diseases with Bone Loss,. We will provide the rationale for developing new anabolic drugs for treatment of bone loss in children. Three different approaches for drug discovery will be described, and new development of bone biology related to drug discovery target will be discussed in detail. Finally, we will talk about dru
板凳
發(fā)表于 2025-3-22 02:24:18 | 只看該作者
地板
發(fā)表于 2025-3-22 05:24:36 | 只看該作者
ing these drugs in the pediatric population.Highlights the p.Bone Drugs in Pediatrics. brings together in one place the evidence for the use of certain drugs in the treatment and prevention of bone loss in children, as well as the reservations still present in the pediatric community regarding their
5#
發(fā)表于 2025-3-22 10:22:57 | 只看該作者
https://doi.org/10.1007/978-3-662-12301-0thyroid hormone-related peptide, and their analogs. We also consider new molecules that are currently under development or of interest, including cathepsin K inhibitors, antisclerostin antibody, and nitric oxide.
6#
發(fā)表于 2025-3-22 15:57:44 | 只看該作者
7#
發(fā)表于 2025-3-22 17:04:10 | 只看該作者
8#
發(fā)表于 2025-3-22 22:36:24 | 只看該作者
9#
發(fā)表于 2025-3-23 02:00:04 | 只看該作者
Growth Hormone and Bone,. To improve linear growth and bone mineral metabolism, some recent studies have challenged GH treatment in patients with metabolic bone diseases, in addition to approved diseases. In this chapter, we describe the physiology of GH action, efficacy, and trials of GH treatment. The especially on bone mineral metabolism.
10#
發(fā)表于 2025-3-23 06:09:08 | 只看該作者
Growth Hormone and Oxandrolone in Burned Children,g post-burn bone health outcomes. The systemic action of these anabolic agents beyond the bone metabolic system has also been explored in the clinical trials described. However, only bone-related markers are discussed in detail in this chapter.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 00:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
孟津县| 新营市| 巴楚县| 额济纳旗| 阿巴嘎旗| 铜山县| 黔南| 长兴县| 屯昌县| 河池市| 金沙县| 溧阳市| 中江县| 黔西县| 林芝县| 鄢陵县| 武冈市| 基隆市| 宁城县| 绥江县| 荆门市| 手机| 龙川县| 景洪市| 孝昌县| 嘉善县| 星子县| 基隆市| 冀州市| 沙洋县| 沐川县| 三原县| 延长县| 和田市| 砀山县| 天长市| 延津县| 南靖县| 滕州市| 石台县| 林甸县|